SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001657312-22-000016
Filing Date
2022-05-03
Accepted
2022-05-03 08:24:55
Documents
56
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q vrna-20220331.htm   iXBRL 10-Q 706870
2 EX-10.1 svb-second_amendmentxtox.htm EX-10.1 8933
3 EX-31.1 exhibit311q122.htm EX-31.1 8987
4 EX-31.2 exhibit312q122.htm EX-31.2 9054
5 EX-32.1 exhibit321q122.htm EX-32.1 5238
6 EX-32.2 exhibit322q122.htm EX-32.2 5395
12 GRAPHIC svb-second_amendmentxtox001.jpg GRAPHIC 211857
13 GRAPHIC svb-second_amendmentxtox002.jpg GRAPHIC 249917
14 GRAPHIC svb-second_amendmentxtox003.jpg GRAPHIC 132616
15 GRAPHIC svb-second_amendmentxtox004.jpg GRAPHIC 66782
  Complete submission text file 0001657312-22-000016.txt   4101946

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vrna-20220331.xsd EX-101.SCH 25138
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vrna-20220331_cal.xml EX-101.CAL 44676
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vrna-20220331_def.xml EX-101.DEF 60482
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vrna-20220331_lab.xml EX-101.LAB 307495
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vrna-20220331_pre.xml EX-101.PRE 185610
50 EXTRACTED XBRL INSTANCE DOCUMENT vrna-20220331_htm.xml XML 385865
Mailing Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE
Business Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE 011-44-0-2032834200
Verona Pharma plc (Filer) CIK: 0001657312 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38067 | Film No.: 22884701
SIC: 2834 Pharmaceutical Preparations